Population-based and family-based association study of 5′UTR polymorphism of the reelin gene and schizophrenia
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Reelin is a glycoprotein involved in the migration and positioning of proliferating neurons and synaptic connectivity during neurodevelopment. It may also modulate neuronal plasticity throughout life. Therefore, the reelin gene is a candidate gene for schizophrenia. We examined the association of the CGG repeat polymorphism in the 5'-untranslated region of the reelin gene with schizophrenia in 266 unrelated French Caucasian patients, 156 of their parents, and 103 controls. We found no difference in the allele distribution between patients and controls although there was a significant higher prevalence of the genotype 8-8 in controls (CLUMP T3: chi(2) = 6.3, P = 0.035). There was no significant transmission disequilibrium in intrafamilial analysis. To refine our phenotypic characterization and in accordance with converging evidence suggesting that treatment resistance is associated with indices of abnormal neurodevelopment, we studied the association between reelin gene polymorphism and response to antipsychotics. Patients who responded to antipsychotics had a higher frequency of both the (CGG)(10) allele and (CGG)(10)-containing genotypes (P = 0.02; P = 0.006, respectively), with an odd ratio for genotypes of 4.2 (CI = [1.4;12.4]). Our results weakly support an association of reelin gene variants with schizophrenia as a whole, yet suggest that reelin could be associated with treatment-resistant schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 2×
“Wehavepreviously reported that BDNF gene variants are associated with antipsychotic response in patients [Krebs et al., 2000] and BDNF is known to directly regulate the expression of reelin [Ringstedt et al., 1998].”
BackgroundIs schizophrenia a neurodevelopmental disorder?
Murray, R. M., & Lewis, S. W. (1987) · BMJ · doi:10.1136/bmj.295.6600.681 · Cited by 889
Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning
Weeber, E. J., Beffert, U., Jones, C., Christian, J. M., Förster, E., Sweatt, J. D., & Herz, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205147200 · Cited by 623 · cited 1×
“This has raised the idea that post-natally expressed reelin could modulate post-natal neuronal plasticity [Costa et al., 2001;Weeber et al., 2002].”
BackgroundBayer, T. A., Falkai, P., & Maier, W. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00039-4 · Cited by 346 · cited 2×
“The neurodevelopmental hypothesis of schizophrenia has become the prevailing pathogenic model of this disorder in agreement with epidemiological, clinical, and neurobiological findings [Murray and Lewis, 1987, 1994; Weinberger, 1987, 1995] and involves both genetic and environmental predisposing factors [Bayer et al.,…”
ResultReelin gene alleles and haplotypes as a factor predisposing to autistic disorder
Persico, A. M., D'Agruma, L., Maiorano, N., Totaro, A., Militerni, R., Bravaccio, C., Wassink, T. H., Schneider, C., Melmed, R., Trillo, S., et al. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000850 · Cited by 337 · cited 3×
“The longer triplet repeats (more than 10) in this region were associated with autistic vulnerability in one study [Persico et al., 2001] but those findings were not replicated [Krebs et al., 2002].”
ResultInfluentialCurran, T., & D'Arcangelo, G. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00035-0 · Cited by 246 · cited 1×
“Reelin is a glycoprotein regulating the positioning and trophism of cortical pyramidal neurons, interneurons and Purkinje cells during brain development [Curran and D’Arcangelo, 1998].”
Background
Cited by
Shifman, S., Johannesson, M., Bronstein, M., Chen, S. X., Collier, D. A., Craddock, N. J., Kendler, K. S., Li, T., O'Donovan, M., O'Neill, F. A., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.0040028 · Cited by 345
The involvement of Reelin in neurodevelopmental disorders
Folsom, T. D., & Fatemi, S. H. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.015 · Cited by 275
“A number of negative gene association studies between RELN and schizophrenia have been published as well (Akahane et al. 2002; Chang et al. 2011; Goldberger et al. 2005; Huang and Chen, 2006).”
BackgroundThe Reelin signaling pathway promotes dendritic spine development in hippocampal neurons
Niu, S., Yabut, O., & D'Arcangelo, G. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1917-08.2008 · Cited by 266
“Genetic association studies also supported an association of RELN gene variants with treatment-resistant schizophrenia (Goldberger et al., 2005), particularly in women (Shifman et al.”
ResultAdult neurogenesis and neurodegenerative diseases: A systems biology perspective
Horgusluoglu, E., Nudelman, K., Nho, K., & Saykin, A. J. (2017) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32429 · Cited by 174
Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases
Knuesel, I. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.002 · Cited by 89
Li, W., Guo, X., & Xiao, S. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.10.014 · Cited by 31
Metadata
- Authors
- Goldberger, C., Gourion, D., Leroy, S., Schürhoff, F., Bourdel, M.-C., Leboyer, M., & Krebs, M.-O.
- Venue
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Publisher
- Wiley
- Published
- 2005-08-05
- Volume
- 137B
- Issue
- 1
- Pages
- 51-55
- ISSN
- 1552-4841 (ISSN-L)
- 1552-485X
- OpenAlex
- W2068564214
- Cited by
- 46
- References
- 6
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.